(2024)
Nanobody-mediated neutralization of candidalysin prevents epithelial damage and inflammatory responses that drive vulvovaginal candidiasis pathogenesis.
mBio 15(3),
e0340923.
Paul Rudolph
Applied Systems Biology · FungiNet / JSMC +49 3641 532-1079 paul.rudolph@leibniz-hki.deCurriculum vitae
Main Research Areas
- Spatio-temporal modelling of the innate immune sytsem for fungal infections
Professional Career
| Since 2020 | PhD student in Bioinformatics at the Hans Knöll Institute |
| 2019 | M.Sc. in Computational and Data Science at the Friedrich Schiller University Jena |
| 2014-2016 | IT-Consultant at ATOS SE in Tuebingen |
| 2014 | B.Eng. in Information Technology at Baden-Wuerttemberg Cooperative State University |
Publications
(2023)
Surrogate infection model predicts optimal alveolar macrophage number for clearance of Aspergillus fumigatus infections.
NPJ Syst Biol Appl 9,
12.
(2022)
Acceptance of different self-sampling methods for semiweekly SARS-CoV-2 testing in asymptomatic children and childcare workers at German Day Care Centers: A nonrandomized controlled trial.
JAMA Netw Open 5(9),
e2231798.
(2022)
Feasibility of SARS-CoV-2 surveillance testing among children and childcare workers at German Day Care Centers: A nonrandomized controlled trial.
JAMA Netw Open 5(1),
e2142057.
